JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, J. E.
Right arrow Articles by Polakis, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, J. E.
Right arrow Articles by Polakis, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 45, Issue of November 8, 1996 pp. 28630-28635
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1

(Received for publication, May 10, 1996, and in revised form, September 20, 1996)

James E. Thomas Dagger , Melanie Smith Dagger , Bonnee Rubinfeld , Magda Gutowski Dagger , Richard P. Beckmann Dagger and Paul Polakis

From Dagger  Cancer Research, Lilly Research Laboratories, Eli Lilly and Co., Lilly Corporate Center, Indianapolis, Indiana 46285 and  Onyx Pharmaceuticals, Inc., Richmond, California 94806

The breast cancer susceptibility gene BRCA1 encodes an 1863-amino acid protein that acts as a tumor suppressor. The biochemical function of BRCA1 is unknown, and there are conflicting results describing its subcellular location. We have identified a 220-kDa protein, which is reactive with three antibodies raised against the amino- and carboxyl-terminal regions of BRCA1. Immunoflourescence staining with an antibody to the carboxyl terminus of BRCA1 localized the protein to the nucleus of breast, ovarian, and cervical carcinoma-derived cell lines. A similar result was observed by biochemical subcellular fractionation that indicated that the 220-kDa protein was localized primarily to the nucleus of cell lines established from breast carcinomas. In addition to the 220-kDa protein, one antibody, C-20, also recognized a 180-kDa protein in MDA-MB-468 total cell lysates that was not detected by the other two antibodies. Several observations suggest the 180-kDa protein is the epidermal growth factor (EGF) receptor: (i) C-20 reacted avidly with a 180-kDa protein immunoprecipitated by an antibody to the EGF receptor; (ii) an EGF receptor antibody detected a 180-kDa protein immunoprecipitated by C-20; (iii) the affinity purified EGF receptor was both immunoprecipitated and detected on immunoblots by the C-20 antibody but not another BRCA1 antibody; (iv) similar phosphopeptide maps were generated from the EGF receptor and the 180-kDa protein immunoprecipitated by C-20, and this peptide map was distinct from the 220-kDa phosphoprotein; and (v) the C-20 immunizing peptide bears sequence identity to the EGF receptor. These results indicate that BRCA1 is a 220-kDa nuclear protein and that the 180-kDa protein reported previously may be unrelated to BRCA1.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K.-F. Lau, W.-M. Chan, M. S. Perkinton, E. L. Tudor, R. C. C. Chang, H.-Y. E. Chan, D. M. McLoughlin, and C. C. J. Miller
Dexras1 Interacts with FE65 to Regulate FE65-Amyloid Precursor Protein-dependent Transcription
J. Biol. Chem., December 12, 2008; 283(50): 34728 - 34737.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Kang, H. J. Kim, S. K. Kim, R. Barouki, C.-H. Cho, K. K. Khanna, E. M. Rosen, and I. Bae
BRCA1 Modulates Xenobiotic Stress-inducible Gene Expression by Interacting with ARNT in Human Breast Cancer Cells
J. Biol. Chem., May 26, 2006; 281(21): 14654 - 14662.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
F. Al-Mulla, M. Abdulrahman, G. Varadharaj, N. Akhter, and J. T. Anim
BRCA1 Gene Expression in Breast Cancer: A Correlative Study between Real-time RT-PCR and Immunohistochemistry
J. Histochem. Cytochem., May 1, 2005; 53(5): 621 - 629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ouchi, N. Fujiuchi, K. Sasai, H. Katayama, Y. A. Minamishima, P. P. Ongusaha, C. Deng, S. Sen, S. W. Lee, and T. Ouchi
BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition
J. Biol. Chem., May 7, 2004; 279(19): 19643 - 19648.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Z. Muresan and V. Muresan
A phosphorylated, carboxy-terminal fragment of {beta}-amyloid precursor protein localizes to the splicing factor compartment
Hum. Mol. Genet., March 1, 2004; 13(5): 475 - 488.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. LaVoie and D. J. Selkoe
The Notch Ligands, Jagged and Delta, Are Sequentially Processed by {alpha}-Secretase and Presenilin/{gamma}-Secretase and Release Signaling Fragments
J. Biol. Chem., September 5, 2003; 278(36): 34427 - 34437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. T. Kimberly, J. B. Zheng, S. Y. Guenette, and D. J. Selkoe
The Intracellular Domain of the beta -Amyloid Precursor Protein Is Stabilized by Fe65 and Translocates to the Nucleus in a Notch-like Manner
J. Biol. Chem., October 19, 2001; 276(43): 40288 - 40292.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. M. Pao, R. Janknecht, H. Ruffner, T. Hunter, and I. M. Verma
CBP/p300 interact with and function as transcriptional coactivators of BRCA1
PNAS, February 1, 2000; 97(3): 1020 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. H. Spain, C. J. Larson, L. S. Shihabuddin, F. H. Gage, and I. M. Verma
Truncated BRCA2 is cytoplasmic: Implications for cancer-linked mutations
PNAS, November 23, 1999; 96(24): 13920 - 13925.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Ruffner, W. Jiang, A. G. Craig, T. Hunter, and I. M. Verma
BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site
Mol. Cell. Biol., July 1, 1999; 19(7): 4843 - 4854.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Jin, X. L. Xu, M.-C. W. Yang, F. Wei, T.-C. Ayi, A. M. Bowcock, and R. Baer
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains
PNAS, October 28, 1997; 94(22): 12075 - 12080.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
F. Durocher, J. Simard, J. Ouellette, V. Richard, F. Labrie, and G. Pelletier
Localization of BRCA1 Gene Expression in Adult Cynomolgus Monkey Tissues
J. Histochem. Cytochem., September 1, 1997; 45(9): 1173 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ruffner and I. M. Verma
BRCA1 is a cell cycle-regulated nuclear phosphoprotein
PNAS, July 8, 1997; 94(14): 7138 - 7143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Thangaraju, S. H. Kaufmann, and F. J. Couch
BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines
J. Biol. Chem., October 20, 2000; 275(43): 33487 - 33496.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.